Braintree (marketing rights of BLI-800) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Braintree (marketing rights of BLI-800) General Information

Description

Portfolio of rights to a colonic-cleansing product. The portfolio consists of manufacturing, marketing and distribution rights of Braintree's proprietary formulation BLI-800 for colonic cleansing before diagnostic procedures for colorectal cancer screening.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Other Industries
Other Business Products and Services
Corporate Office
  • Paris
  • France

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Braintree (marketing rights of BLI-800) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Braintree (marketing rights of BLI-800)‘s full profile, request access.

Request a free trial

Braintree (marketing rights of BLI-800) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Braintree (marketing rights of BLI-800)‘s full profile, request access.

Request a free trial

Braintree (marketing rights of BLI-800) FAQs

  • Where is Braintree (marketing rights of BLI-800) headquartered?

    Braintree (marketing rights of BLI-800) is headquartered in Paris, France.

  • What industry is Braintree (marketing rights of BLI-800) in?

    Braintree (marketing rights of BLI-800)’s primary industry is Buildings and Property.

  • Is Braintree (marketing rights of BLI-800) a private or public company?

    Braintree (marketing rights of BLI-800) is a Private company.

  • What is Braintree (marketing rights of BLI-800)’s current revenue?

    The current revenue for Braintree (marketing rights of BLI-800) is 000000.

  • Who are Braintree (marketing rights of BLI-800)’s investors?

    Braintree has invested in Braintree (marketing rights of BLI-800).

  • When was Braintree (marketing rights of BLI-800) acquired?

    Braintree (marketing rights of BLI-800) was acquired on 09-Oct-2009.

  • Who acquired Braintree (marketing rights of BLI-800)?

    Braintree (marketing rights of BLI-800) was acquired by Ipsen (Pharmaceuticals).

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »